ADXN
Addex Therapeutics·NASDAQ
--
--(--)
--
--(--)
ADXN fundamentals
During Q3 2025, Addex Therapeutics (ADXN) reported revenue of 62.26K, a YoY change of -9.89%. Net income was -1.98M, a YoY change of -9.27%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | TTM |
|---|
Start Date | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | -- |
End Date | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 939.09K -- | 909.26K -- | 29.67K -- | 2.06M -- | 896.39K -4.55% | 1.07M +17.98% | 730.27K +2361.03% | 434.60K -78.90% | 257.56K -71.27% | 191.99K -82.10% | 415.86K -43.05% | 641.09K +47.51% | 548.68K +113.03% | 705.13K +267.27% | 358.53K -13.79% | 182.57K -71.52% | 258.99K -52.80% | 128.20K -81.82% | 69.10K -80.73% | 1.66K -99.09% | -- -- | 45.82K -64.26% | 62.26K -9.89% | -- -- |
Sales and Services Revenue | 939.09K -- | 909.26K -- | 29.67K -- | 2.36M -- | 896.39K -4.55% | 1.07M +17.98% | 730.27K +2361.03% | 693.73K -70.61% | 257.56K -71.27% | 191.99K -82.10% | 415.86K -43.05% | 665.46K -4.08% | 548.68K +113.03% | 705.13K +267.27% | 360.16K -13.40% | 183.16K -72.48% | 260.58K -52.51% | 128.20K -81.82% | 63.76K -82.30% | 8.21K -95.52% | 80.35K -69.16% | 45.82K -64.26% | 62.26K -2.34% | 196.65K -- |
Other Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 5.34K -- | -6.55K -- | -- -- | -- -- | 0 -100.00% | -- -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | 939.09K -- | 909.26K -- | 29.67K -- | -2.03M -- | 896.39K -4.55% | 1.07M +17.98% | 730.27K +2361.03% | -2.75M -35.86% | 257.56K -71.27% | 191.99K -82.10% | 415.86K -43.05% | -898.18K +67.39% | 548.68K +113.03% | 705.13K +267.27% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 5.43M -- | 4.13M -- | 3.50M -- | 4.27M -- | 4.32M -20.37% | 6.03M +46.11% | 4.64M +32.59% | 5.11M +19.74% | 6.52M +50.88% | 7.62M +26.42% | 4.65M +0.31% | -6.37M -224.48% | 952.68K -85.39% | 1.15M -84.92% | 1.18M -74.65% | 1.05M +116.52% | 1.13M +19.11% | 1.13M -1.81% | 805.95K -31.69% | 493.09K -53.11% | 765.94K -32.50% | 969.10K -14.11% | 936.20K +16.16% | 3.16M -- |
Selling, General and Administrative Expenses | 1.74M -- | 1.68M -- | 1.35M -- | 1.42M -- | 1.40M -19.18% | 2.00M +19.03% | 1.58M +17.05% | 1.29M -9.08% | 2.43M +73.28% | 1.60M -19.64% | 1.85M +17.21% | -2.00M -255.30% | 672.95K -72.34% | 823.28K -48.67% | 643.00K -65.18% | 874.21K +143.70% | 862.87K +28.22% | 750.97K -8.78% | 563.75K -12.33% | 421.02K -51.84% | 589.45K -31.69% | 673.75K -10.28% | 649.58K +15.22% | 2.33M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | 6.50M -- | -- -- | -- -- | -- -- | 6.36M -2.17% | -- -- | -- -- | -- -- | 4.05M -36.35% | -- -- | -- -- | 643.00K -- | 874.21K -78.41% | 862.87K -- | 750.97K -- | 563.75K -12.33% | 421.02K -51.84% | 589.45K -31.69% | 673.75K -10.28% | 649.58K +15.22% | 2.33M -- |
Research and Development Expenses | 3.69M -- | 2.45M -- | 2.15M -- | 2.85M -- | 2.92M -20.93% | 4.03M +64.65% | 3.06M +42.30% | 3.83M +34.05% | 4.09M +40.10% | 6.02M +49.21% | 2.81M -8.37% | -4.36M -214.10% | 279.73K -93.16% | 325.89K -94.58% | 536.80K -80.88% | 177.35K +104.06% | 271.91K -2.80% | 377.35K +15.79% | 242.20K -54.88% | 72.07K -59.37% | 176.49K -35.09% | 295.36K -21.73% | 286.62K +18.34% | 830.53K -- |
Operating Income | -4.49M -- | -3.22M -- | -3.47M -- | -1.91M -- | -3.43M +23.68% | -4.96M -54.06% | -3.91M -12.68% | -4.42M -131.44% | -6.26M -82.84% | -7.43M -49.91% | -4.24M -8.41% | 7.03M +259.08% | -404.00K +93.55% | -444.04K +94.02% | -819.65K +80.66% | -868.40K -112.35% | -874.20K -116.39% | -1.00M -125.23% | -736.85K +10.10% | -491.43K +43.41% | -685.58K +21.58% | -923.28K +7.68% | -873.93K -18.60% | -2.97M -- |
Non-Operating Income (Loss) | 15.74K -- | -73.17K -- | -135.63K -- | -493.83K -- | 622.86K +3857.17% | -112.64K -53.94% | 57.20K +142.17% | -417.45K +15.47% | -59.10K -109.49% | -131.88K -17.08% | 66.65K +16.53% | -160.47K +61.56% | -1.31K +97.78% | -138.72K -5.19% | 42.12K -36.81% | -200.02K -24.65% | 58.70K +4572.72% | -619.93K -346.89% | -1.07M -2645.60% | -820.69K -310.30% | -979.99K -1769.61% | -1.54M -149.14% | -1.11M -3.15% | -4.45M -- |
Income (Loss) from Affiliates | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | -590.25K -- | -1.04M -- | -850.77K -- | -958.33K -- | -1.55M -162.91% | -1.10M -6.64% | -4.47M -- |
Gain (Loss) on Foreign Currency Exchange | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 27.77K -- | 164.29K -- | -- -- | -- -- | -35.48K -227.76% | 12.51K -92.39% | -- -- | -- -- | -433.09 +98.78% | -- -- |
Other Non-Operating Income (Loss) | 50.27K -- | 75.59K -- | 82.05K -- | -220.95K -- | 83.03K +65.17% | 85.69K +13.36% | 81.14K -1.11% | -255.04K -15.43% | 7.29K -91.23% | 3.23K -96.23% | 6.38K -92.14% | -17.40K +93.18% | 1.27K -82.63% | 1.23K -61.99% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Interest Expense | 34.53K -- | 148.76K -- | 217.68K -- | 272.87K -- | -539.83K -1663.33% | 198.33K +33.32% | 23.94K -89.00% | 162.41K -40.48% | 66.39K +112.30% | 135.12K -31.87% | -60.27K -351.71% | 143.06K -11.91% | 2.58K -96.12% | 139.95K +3.58% | -14.35K +76.19% | 364.31K +154.65% | -58.70K -2377.23% | 29.69K -78.79% | 573.19 +103.99% | -17.57K -104.82% | 21.66K +136.89% | -7.35K -124.74% | 592.52 +3.37% | -2.66K -- |
Interest Expense | 57.31K -- | 160.21K -- | 219.07K -- | 274.29K -- | 22.02K -61.57% | 24.79K -84.53% | 10.70K -95.12% | 10.22K -96.28% | 66.49K +201.94% | 135.33K +445.89% | -56.61K -629.27% | 170.49K +1568.80% | 28.68K -56.87% | 154.87K +14.44% | 588.56 +101.04% | 213.49K +25.22% | 677.76 -97.64% | 29.69K -80.83% | 693.98 +17.91% | 1.64K -99.23% | 21.66K +3095.16% | -- -- | 592.52 -14.62% | -- -- |
Interest Income | 22.78K -- | 11.45K -- | 1.39K -- | 1.42K -- | 561.85K +2366.92% | -173.54K -1615.14% | -13.25K -1051.01% | -152.19K -10821.31% | 103.14 -99.98% | 214.66 +100.12% | 3.66K +127.63% | 27.43K +118.02% | 26.10K +25204.67% | 14.92K +6850.56% | 14.94K +308.15% | -150.82K -649.87% | 59.37K +127.49% | -- -- | 120.8 -99.19% | 19.20K +112.73% | 0 -100.00% | 7.35K -- | 0 -100.00% | 26.55K -- |
Pretax Income From Continuing Operations | -4.47M -- | -3.29M -- | -3.61M -- | -2.40M -- | -2.80M +37.34% | -5.07M -54.06% | -3.85M -6.85% | -4.84M -101.25% | -6.32M -125.59% | -7.56M -49.18% | -4.17M -8.29% | 6.87M +242.03% | -405.31K +93.59% | -582.76K +92.29% | -777.53K +81.36% | -1.07M -115.55% | -815.51K -101.20% | -1.62M -178.00% | -1.81M -132.67% | -1.31M -22.81% | -1.67M -104.24% | -2.47M -52.33% | -1.98M -9.45% | -7.43M -- |
Income Tax Expense | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- |
Income from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -10.82M -- | -2.23M -- | -2.41M -- | -2.09M -- | -2.33M +78.46% | -2.61M -16.91% | 15.94M +762.27% | -2.84K +99.86% | -17.54K +99.25% | 0 +100.00% | 148.33K -99.07% | 0 +100.00% | 130.79K -- |
Net Income | -4.47M -- | -3.29M -- | -3.61M -- | -2.40M -- | -2.80M +37.34% | -5.07M -54.06% | -3.85M -6.85% | -4.84M -101.25% | -6.32M -125.59% | -7.56M -49.18% | -4.17M -8.29% | -3.95M +18.31% | -2.64M +58.29% | -2.99M +60.46% | -2.86M +31.38% | -3.40M +13.98% | -3.42M -29.87% | 14.32M +579.01% | -1.81M +36.71% | -1.33M +60.88% | -1.67M +51.36% | -2.32M -116.19% | -1.98M -9.27% | -7.29M -- |
Net Income Attributable to Owners of the Company | -4.47M -- | -3.29M -- | -3.61M -- | -2.40M -- | -2.80M +37.34% | -5.07M -54.06% | -3.85M -6.85% | -4.84M -101.25% | -6.32M -125.59% | -7.56M -49.18% | -4.17M -8.29% | -3.95M +18.31% | -2.64M +58.29% | -2.99M +60.46% | -2.86M +31.38% | -3.40M +13.98% | -3.42M -29.87% | 14.32M +579.01% | -1.81M +36.71% | -1.33M +60.88% | -1.67M +51.36% | -2.32M -116.19% | -1.98M -9.27% | -7.29M -- |
Net Income Attributable to Common Stockholders | -4.47M -- | -3.29M -- | -3.61M -- | -2.40M -- | -2.80M +37.34% | -5.07M -54.06% | -3.85M -6.85% | -4.84M -101.25% | -6.32M -125.59% | -7.56M -49.18% | -4.17M -8.29% | -3.95M +18.31% | -2.64M +58.29% | -2.99M +60.46% | -2.86M +31.38% | -3.40M +13.98% | -3.42M -29.87% | 14.32M +579.01% | -1.81M +36.71% | -1.33M +60.88% | -1.67M +51.36% | -2.32M -116.19% | -1.98M -9.27% | -7.29M -- |
Other Comprehensive Income | 192.08K -- | -240.64K -- | -164.79K -- | -48.97K -- | 133.64K -30.42% | 137.57K +157.17% | 89.28K +154.18% | -83.40K -70.31% | 722.88K +440.90% | 501.74K +264.71% | 134.99K +51.20% | -8.78K +89.47% | -33.48K -104.63% | -152.00K -130.29% | -27.82K -120.61% | -376.19K -4185.43% | -54.04K -61.43% | -58.28K +61.66% | -118.08K -324.42% | -233.82K +37.84% | 74.66K +238.16% | -16.13K +72.32% | -69.51K +41.14% | -244.80K -- |
Total Comprehensive Income | -4.28M -- | -3.53M -- | -3.77M -- | -2.45M -- | -2.67M +37.65% | -4.93M -39.67% | -3.76M +0.19% | -4.92M -100.63% | -5.60M -109.80% | -7.06M -43.17% | -4.04M -7.27% | -3.96M +19.51% | -2.67M +52.31% | -3.14M +55.49% | -2.89M +28.40% | -3.78M +4.67% | -3.48M -30.27% | 14.26M +553.98% | -1.93M +33.24% | -1.56M +58.58% | -1.59M +54.26% | -2.34M -116.37% | -2.05M -6.19% | -7.54M -- |
Total Comprehensive Income Attributable to Minority Interests | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -2.66M -- | -- -- | -- -- | -- -- | 0 +100.00% | -- -- | -- -- | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -4.28M -- | -3.53M -- | -3.77M -- | -2.45M -- | -2.67M +37.65% | -4.93M -39.67% | -3.76M +0.19% | -4.92M -100.63% | -5.60M -109.80% | -7.06M -43.17% | -4.04M -7.27% | -3.96M +19.51% | -2.67M +52.31% | -3.14M +55.49% | -2.89M +28.40% | -3.78M +4.67% | -817.02K +69.40% | 14.26M +553.98% | -1.93M +33.24% | -1.56M +58.58% | -1.59M -94.72% | -2.34M -116.37% | -2.05M -6.19% | -7.54M -- |
Basic EPS | -0.17 -- | -0.13 -- | -0.13 -- | -0.09 -- | -0.08 +52.94% | -0.15 -15.38% | -0.12 +7.69% | -0.13 -44.44% | -0.16 -100.00% | -0.2 -33.33% | -0.09 +25.00% | -0.05 +61.54% | -0.04 +75.00% | -0.04 +80.00% | -0.03 +66.67% | -0.03 +40.00% | -0.03 +25.00% | 0.14 +450.00% | -0.02 +33.33% | -0.18 -500.00% | -0.01 +66.67% | -0.03 -121.43% | -0.01 +50.00% | -0.23 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.01 -- | -- -- | -0.01 -- | -0.01 -- | -0.02 -100.00% | -- -- | -0.01 -- | -0.03 -200.00% | -0.01 +50.00% | -- -- |
Basic EPS from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.02 -- | -- -- | -0.02 -- | 0.16 -- | 0 +100.00% | -- -- | 0 +100.00% | 0 -100.00% | 0 -- | -- -- |
Diluted EPS | -0.17 -- | -0.13 -- | -0.13 -- | -- -- | -0.08 +52.94% | -0.15 -15.38% | -0.12 +7.69% | -- -- | -0.16 -100.00% | -0.2 -33.33% | -0.09 +25.00% | -- -- | -0.04 +75.00% | -0.04 +80.00% | -0.03 +66.67% | -- -- | -0.03 +25.00% | 0.14 +450.00% | -0.02 +33.33% | -- -- | -0.01 +66.67% | -0.03 -121.43% | -0.01 +50.00% | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.01 -- | -- -- | -0.01 -- | -0.01 -- | -0.02 -100.00% | -- -- | -0.01 -- | -0.03 -200.00% | -0.01 +50.00% | -- -- |
Diluted EPS from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.02 -- | -- -- | -0.02 -- | 0.16 -- | 0 +100.00% | -- -- | 0 +100.00% | 0 -100.00% | 0 -- | -- -- |
You can ask Aime
What is Addex Therapeutics's latest dividend and current dividend yield?Did Addex Therapeutics beat or miss consensus estimates last quarter?What factors drove the changes in Addex Therapeutics's revenue and profit?What is the market's earnings forecast for Addex Therapeutics next quarter?What were the key takeaways from Addex Therapeutics's earnings call?What does Addex Therapeutics do and what are its main business segments?What is the revenue and EPS growth rate for Addex Therapeutics year over year?What were the key takeaways from Addex Therapeutics’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
